CNS tumor
Showing 1 - 25 of >10,000
Artificial Intelligence in CNS Radiation Oncology
Not yet recruiting
- CNS Tumor
- The images (CT, MRI, PET) used for RT planning, mid-treatment imaging as part of IGRT or disease evaluation, and response assessment/ surveillance post-RT
- (no location specified)
Sep 6, 2023
CNS Germinoma, CNS Tumor, Asian Consortium Trial in Goyang-si (Radiation Therapy)
Recruiting
- CNS Germinoma
- +2 more
- Radiation Therapy
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center, Korea
Aug 7, 2023
Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,
Not yet recruiting
- Rhabdoid Tumor
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 11, 2023
Artificial Intelligence Neuropathologist
Recruiting
- CNS Tumor
- Neuropathology
-
Shanghai, Shanghai, ChinaHushan Hospital, Fudan University
Mar 20, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- SC-CAR4BRAIN
-
Seattle, WashingtonSeattle Children's Hospital
Mar 3, 2023
Pediatric Cancer, CNS Tumor, Childhood, Skin Inflammation Trial in Boston (other, drug, behavioral)
Recruiting
- Pediatric Cancer
- +2 more
- Warm Baths or Showers
- +5 more
-
Boston, Massachusetts
- +1 more
Jan 31, 2022
Sleep Among Long-term Survivors of Childhood Cancer
Not yet recruiting
- ALL, Adult
- +2 more
- Neurocognitive (Thinking) Testing
- +6 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 27, 2022
PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor
Completed
- Brain Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)
Recruiting
- Neuroblastoma
- +2 more
-
Columbus, OhioNationwide Children's Hospital
Dec 20, 2022
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Childhood CNS Tumor Trial in Washington (genetic, radiation, drug)
Not yet recruiting
- Childhood CNS Tumor
- SGT-53
- +4 more
-
Washington, District of ColumbiaChildren's National Medical Center
Feb 7, 2022
Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of
Recruiting
- Diffuse Midline Glioma (DMG)
- +7 more
- ONC206
- Standard of Care Radiation Therapy
-
San Francisco, California
- +2 more
Sep 13, 2022
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,
Not yet recruiting
- Anaplastic Astrocytoma
- +17 more
- (no location specified)
Jun 28, 2023
Neurobehavioral Functioning in Pediatric Brain Tumor Patients
Active, not recruiting
- Brain Tumor
- Central Nervous System Neoplasms
-
Boston, MassachusettsMassachusetts General Hospital
Apr 6, 2022
CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)
Not yet recruiting
- Central Nervous System Neoplasms
- +6 more
- B7-H3-CAR T cells
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 18, 2023
Effectiveness of Care in Certified Cancer Centres in Germany
Completed
- Colorectal Cancer
- +9 more
- Oncological certification
-
Dresden, Sachsen, GermanyTechnische Universität Dresden
Aug 22, 2022
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)
Recruiting
- Ewing Sarcoma
- +5 more
-
Valhalla, New YorkNew York Medical College
Oct 24, 2022
Astroblastoma, BCOR ITD Sarcoma, CNS Sarcoma Trial in Washington
Recruiting
- Astroblastoma
- +3 more
-
Washington, District of ColumbiaChildren's National Hospital
Jan 23, 2023
Non-CNS Tumor Trial (biological, drug, radiation)
Not yet recruiting
- Non-CNS Tumor
- GEN1042
- +2 more
- (no location specified)
Aug 4, 2022
Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant
Recruiting
- Atypical Teratoid Rhabdoid Tumor
- +6 more
- Tazemetostat
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 23, 2023
Brain Slice Explants to Predict Drug Response in Brain Tumors
Not yet recruiting
- Central Nervous System Tumor
- Biospecimen collection
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jul 28, 2023
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)
Active, not recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- EGFR806-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Jan 18, 2023
Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)
Not yet recruiting
- Advanced Solid Tumor
- +2 more
-
Palo Alto, California
- +9 more
Aug 2, 2022
Nervous System Tumor Trial (Administration of Indocyanine Green (ICG) and Visualization of Tumor)
Not yet recruiting
- Nervous System Tumor
- Administration of Indocyanine Green (ICG) and Visualization of Tumor
- (no location specified)
Feb 17, 2023